Wang et al. in 2018 reported that Asiatic acid inhibits NAFLD and decreases expression levels of FAS and SREBP-1 by reducing the extent of ERS [37]. This evidence concerns the gene FAS and metabolic dysfunction-associated steatotic liver disease.